G Protein-Coupled Receptor 119 (GPR119) Agonists for the Treatment of Diabetes: Recent Progress and Prevailing Challenges

GPR119 agonists: Novel therapeutic agents for type 2 diabetes mellitus - ScienceDirect

Figure 2 from GPR119 Agonists: A Novel Strategy for Type 2 Diabetes Treatment

G protein-coupled receptors as targets for anti-diabetic therapeutics

Frontiers ZB-16, a Novel GPR119 Agonist, Relieves the Severity of Streptozotocin–Nicotinamide-Induced Diabetes in Rats

GPR119 Agonists: A Novel Strategy for Type 2 Diabetes Treatment

GPR119 cell line G-protein coupled receptor 119 (GPR119) Cell Line-XP_066873.1

Activation and signaling mechanism revealed by GPR119-Gs complex structures

Deciphering G-Protein-Coupled Receptor 119 Agonists as Promising Strategy against Type 2 Diabetes Using Systems Biology Approach

GPR119 agonists: Novel therapeutic agents for type 2 diabetes mellitus - ScienceDirect

The current state of GPCR‐based drug discovery to treat metabolic disease - Sloop - 2018 - British Journal of Pharmacology - Wiley Online Library

Schematic diagram illustrating mechanism by which GPR119 ligand